Capital Fund Management S.A. Sells 9,872 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB)

Capital Fund Management S.A. cut its holdings in shares of Silicon Laboratories Inc. (NASDAQ:SLAB) by 17.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 46,074 shares of the semiconductor company’s stock after selling 9,872 shares during the period. Capital Fund Management S.A. owned about 0.14% of Silicon Laboratories worth $5,723,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Jones Financial Companies Lllp boosted its stake in Silicon Laboratories by 44.5% in the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 69 shares in the last quarter. Headlands Technologies LLC acquired a new position in Silicon Laboratories during the 4th quarter worth about $70,000. Venturi Wealth Management LLC grew its holdings in Silicon Laboratories by 207.0% during the 4th quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company’s stock worth $98,000 after acquiring an additional 530 shares during the last quarter. Asset Management One Co. Ltd. acquired a new stake in Silicon Laboratories in the 4th quarter valued at about $117,000. Finally, KBC Group NV raised its stake in shares of Silicon Laboratories by 42.1% in the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company’s stock worth $159,000 after acquiring an additional 379 shares during the last quarter.

Analyst Ratings Changes

Several analysts have recently commented on SLAB shares. Needham & Company LLC reissued a “buy” rating and set a $150.00 price target on shares of Silicon Laboratories in a research note on Wednesday, March 12th. Benchmark reiterated a “buy” rating and issued a $160.00 price objective on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Stifel Nicolaus boosted their target price on Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Susquehanna initiated coverage on Silicon Laboratories in a report on Tuesday, December 17th. They issued a “neutral” rating and a $130.00 price target on the stock. Finally, StockNews.com cut Silicon Laboratories from a “hold” rating to a “sell” rating in a report on Thursday, March 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $136.20.

Silicon Laboratories Price Performance

Shares of SLAB stock opened at $89.82 on Friday. The stock has a market cap of $2.92 billion, a PE ratio of -15.12 and a beta of 1.33. The stock has a 50-day moving average of $127.57 and a 200-day moving average of $122.46. Silicon Laboratories Inc. has a one year low of $82.82 and a one year high of $160.00.

Silicon Laboratories (NASDAQ:SLAB) last issued its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, meeting the consensus estimate of ($0.11). The firm had revenue of $166.25 million during the quarter, compared to the consensus estimate of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business’s quarterly revenue was up 91.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($1.19) earnings per share. As a group, research analysts anticipate that Silicon Laboratories Inc. will post -0.97 earnings per share for the current year.

Insider Buying and Selling

In other Silicon Laboratories news, Director Navdeep S. Sooch sold 2,360 shares of Silicon Laboratories stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the transaction, the director now owns 400,567 shares of the company’s stock, valued at approximately $59,684,483. The trade was a 0.59 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director William G. Bock sold 1,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total transaction of $149,430.00. Following the sale, the director now directly owns 31,115 shares of the company’s stock, valued at $4,649,514.45. This represents a 3.11 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,360 shares of company stock valued at $782,610. 1.60% of the stock is owned by company insiders.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.